Proactive Investors - Run By Investors For Investors

Cambridge Cognition signals move into wearable tech

It is teaming up with design and research agency Ctrl Group to produce novel digital health applications for new markets, with prototype products expected in the second half of 2016.
Cambridge Cognition signals move into wearable tech
Common mental health disorders such as dementia, depression and anxiety are characterised by symptoms that can fluctuate regularly

Cambridge Cognition (AIM: COG), which specialises in cognitive assessment technologies, is moving into the wearable technologies field.

It is teaming up with London-based design and research agency Ctrl Group to produce novel digital health applications for new markets, with prototype products expected in the second half of 2016.

Digital health products are being designed and developed enabling near-user cognitive testing via wearable and smart devices. More meaningful cognitive data will enable healthcare practitioners to detect mental health risk factors earlier, reduce the likelihood of relapse and, by tracking daily activity, help individuals to better understand and manage their cognitive health in a way that other products have for physical health.

For pharmaceutical companies, understanding the real world impact of interventions will support clinical trials of drug development candidates and marketed treatments for chronic diseases, Cambridge Cognition said.

Initially, the new range of products will be licensed to pharmaceutical and healthcare providers through relationships established by both Cambridge Cognition and Ctrl Group.

“The move to near-user cognitive measures on consumer electronics marks a significant step for Cambridge Cognition in realising the company's aim to become the world leader in cognitive healthcare technologies," said Dr Steven Powell, chief executive officer of Cambridge Cognition.

Ctrl Group co-founder Ben Fehnert said the company was delighted to be working with Cambridge Cognition, and that it saw a “huge advantage in being able to understand cognition in daily life through wearable and smart technologies”.

Cambridge Cognition's shares were up a halfpenny at 68p in afternoon trading.


Register here to be notified of future COG Company articles
View full COG profile

Cambridge Cognition Timeline

Related Articles

representation of top level web domains on a giant keyboard
September 07 2016
Interim results show a 468% jump in bookings for the six months ended June 30, which in turn highlights the scaling up that's underway for CentralNic and the web domains that it supports.
Amazon online
October 13 2016
The focus has been on generating revenue from existing projects on a recurring basis and on closing new deals
Kevin Spacey holding a blood sample
September 19 2016
Instem currently has more than 500 clients across the globe. It reports a 98% client retention rate, which it says is a “true measure of our success”.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.